Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies third quarter 2024 financial results conference call.

Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...

Dynavax Technologies Corp (DVAX) reports strong financial performance with a 44% market share in the U.S. and a $200 million share repurchase plan.

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

Home remedies for shingles can provide relief from symptoms although they won't cure you of the condition. Natural at-home treatments include therapeutic baths, cool compresses, soothing paste, and ...

Eliminating fake vaccine news with pharmacist, nurse, and physician review.